EVENT & NEWS | CYDAR MEDICAL AND ITS AMBITION IN THE PAST 20 YEARS ON ARTIFICIAL INTELLIGENCE

Tom Carrell from Cydar Medical UK delivered the first presentation on the podium of the 2022 Charing Cross International Symposium (CX) in london UK entitled “Making endovascular aortic repair results more predictable: Artificial intelligence (AI) takes on the challenge of a 20 year old ”. In his talk Tom Carrell posed a question that is at the center of this 20-year-old challenge, the question “Given each individual patient with some anatomical complexity, do we really know—especially with evolving treatment options—what it is? will be the result for them?”.

The Charing Cross International Symposium (CX) is an event about delivering world-class vascular education, taking evidence into account and showcasing innovation. The CX Innovation Exhibition is dedicated to highlighting innovation, what it takes for a physician-inventor to succeed and for innovative ideas in the vascular and endovascular arena to thrive.

Tom carrel had detailed 20 years ago that anatomical severity is a major determinant of outcome and therefore standardized reporting may be necessary. Since those 20 years, With a number of papers on the anatomical severity scoring system published, Tom Carrell concluded that it predicts outcomes and complications. Carell points out that there hasn't been much progress in terms of using that data. There are several reasons one of which is that some of the things that go into the grading scheme are rather complicated. Highlighting that key question, carrell asked AI "Can AI offer that detail and simplicity?". Carell explained that cydar medical is developing extended capabilities to interoperate with what the company calls intelligent Maps.

For products the company currently uses “virtual guidewires” which are used to plan, guide, and review endovascular surgery. A virtual guidewire is used for planning, but its main function is to identify where you will operate, so that your plan is rendered on a map and overlaid on live fluoroscopy. What carrel and Cydar Medical did with intelligent maps was take that capability with the virtual guidewires and AI that cydar medical has in the system and data from thousands of patients who have been treated with Cydar EV Maps and build tools to analyze anatomy. This tool is a combination of deterministic algorithms using virtual wires, using neural network simulation or deep learning to segment blood vessels as well as the aorta and ilium according to each level of exit of the bifurcation. One of the takeaway messages from carrel is the relevance of this software which is useful to help inform decision making by taking one patient who produces an analysis and then match it with another patient who has a similar anatomy in the database. That way it can be known what treatment the patient has.

Tom carrell concludes that Cydar Medical wants to close its 20-year ambition to have feedback there to modify the scoring system.

Deray Global Utama dapat membantu Anda dalam mengurus Alat Kesehatan atau IVD
Hubungi Kami Untuk Konsultasi Gratis